DEM-TACE as the initial treatment could improve the clinical efficacy of the hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study

BACKGROUND: Conventional-transarterial chemoembolization (C-TACE) was proven to improve overall survival (OS) in hepatocellular carcinoma (HCC) patients with portal vein tumor thrombus (PVTT), drug-eluting microsphere-TACE (DEM-TACE) was supposed to provide more benefit than C-TACE in this respect....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Junwei, Lai, Lisha, Luo, Junyang, Wang, Haofan, Li, Mingan, Huang, Mingsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714197/
https://www.ncbi.nlm.nih.gov/pubmed/36451104
http://dx.doi.org/10.1186/s12885-022-10361-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714197/
https://www.ncbi.nlm.nih.gov/pubmed/36451104
http://dx.doi.org/10.1186/s12885-022-10361-5

Ejemplares similares